Dong-A ST and ST Pharm Both Grow in Q3, Sales and Operating Profit Rise Together
Predicted impact: Low
Routine Q3 growth announcement; same results already covered in recent preliminary earnings.
170900 · KOSPI · ₩170900 · 동아에스티
Predicted impact: Low
Routine Q3 growth announcement; same results already covered in recent preliminary earnings.
Predicted impact: Medium
Plant sale to clear debt is a sizeable asset deal, though value is not disclosed.
Predicted impact: Low
Domestic exclusive sales deal for a small AI solution; size undisclosed, likely small versus revenue.
Predicted impact: Low
Analyst target price cut with no new company event or quantified impact.
Predicted impact: Low· Actual: −1.0% vs sector, volume 1.1× normal (5 trading days)
Smart ward collaboration with hospital; no value disclosed, routine.
Also known as: Dong-A ST / 동아에스티 / 170900 / KRX:170900
Source: KRX statistical information